PLEOMORPHIC VARIANT MANTLE CELL LYMPHOMA
Clinical trials for PLEOMORPHIC VARIANT MANTLE CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PLEOMORPHIC VARIANT MANTLE CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for PLEOMORPHIC VARIANT MANTLE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for Tough-to-Treat blood cancer
Disease control OngoingThis study is testing whether two oral medications, venetoclax and acalabrutinib, can help control mantle cell lymphoma that has returned or didn't respond to previous treatments. The trial involves 32 adults who have already tried at least one other therapy. Researchers want to …
Matched conditions: PLEOMORPHIC VARIANT MANTLE CELL LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo aims to control aggressive blood cancer in younger adults
Disease control OngoingThis study is testing a two-part treatment approach for younger patients newly diagnosed with mantle cell lymphoma, an aggressive type of blood cancer. First, patients receive a targeted pill (ibrutinib) plus an immunotherapy drug (rituximab) to attack the cancer cells. If they r…
Matched conditions: PLEOMORPHIC VARIANT MANTLE CELL LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC